PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients
2015
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients
- Ist Teil von
- Journal of hepatology, 2015-09, Vol.63 (3), p.651-660
- Ort / Verlag
- Netherlands: Elsevier B.V
- Erscheinungsjahr
- 2015
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Graphical abstract
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0168-8278eISSN: 1600-0641DOI: 10.1016/j.jhep.2015.03.036Titel-ID: cdi_proquest_miscellaneous_1705476363
- Format
- –
- Schlagworte
- Animals, Carcinoma, Hepatocellular - etiology, Carcinoma, Hepatocellular - mortality, Cell Line, Tumor, Cell Proliferation, Disease Progression, Gastroenterology and Hepatology, Hepatocellular carcinoma, Humans, Liver Neoplasms - etiology, Liver Neoplasms - mortality, MAP Kinase Signaling System, Metastasis, Mice, Niacinamide - analogs & derivatives, Niacinamide - pharmacology, Phenylurea Compounds - pharmacology, Phosphatidylinositol 3-Kinases - physiology, Prognosis, Protein Tyrosine Phosphatase, Non-Receptor Type 11 - physiology, raf Kinases - physiology, Shp2